Cargando…

Current epidemiology of pancreatic cancer: Challenges and opportunities

Pancreatic cancer (PC) is an increasingly common disease worldwide. Having a better understanding of worldwide and regional epidemiologic features and risk factors of PC is essential to identify new approaches for prevention, early diagnosis, surveillance, and treatment. In this article, we review t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Wenhao, Tao, Jinxin, Zheng, Lianfang, Zhang, Taiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797236/ https://www.ncbi.nlm.nih.gov/pubmed/33446994 http://dx.doi.org/10.21147/j.issn.1000-9604.2020.06.04

Ejemplares similares

Novel therapies targeting hypoxia mechanism to treat pancreatic cancer
por: Luo, Wenhao, et al.
Publicado: (2021)

Targeting hypoxic tumor microenvironment in pancreatic cancer
por: Tao, Jinxin, et al.
Publicado: (2021)

Preclinical models of pancreatic ductal adenocarcinoma: challenges and opportunities in the era of precision medicine
por: Yu, Yiqi, et al.
Publicado: (2021)

Novel Discoveries Targeting Pathogenic Gut Microbes and New Therapies in Pancreatic Cancer: Does Pathogenic E. coli Infection Cause Pancreatic Cancer Progression Modulated by TUBB/Rho/ROCK Signaling Pathway? A Bioinformatic Analysis
por: Luo, Wenhao, et al.
Publicado: (2020)

Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theory
por: Luo, Wenhao, et al.
Publicado: (2020)

Is Invagination Anastomosis More Effective in Reducing Clinically Relevant Pancreatic Fistula for Soft Pancreas After Pancreaticoduodenectomy Under Novel Fistula Criteria: A Systematic Review and Meta-Analysis
por: Cao, Zhe, et al.
Publicado: (2020)

MicroRNA-381—A Key Transcriptional Regulator: Its Biological Function and Clinical Application Prospects in Cancer
por: Zeng, Xue, et al.
Publicado: (2020)

The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells
por: Fu, Yibo, et al.
Publicado: (2021)

MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy
por: Cao, Zhe, et al.
Publicado: (2020)

Win or loss? Combination therapy does improve the oncolytic virus therapy to pancreatic cancer
por: Luo, Wenhao, et al.
Publicado: (2022)

Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications
por: Qiu, Jiangdong, et al.
Publicado: (2018)

Cancer-specific survival and metastasis in pancreatic mucinous cystadenocarcinoma: A SEER-based cohort study
por: Wang, Ruobing, et al.
Publicado: (2022)

PRKRA promotes pancreatic cancer progression by upregulating MMP1 transcription via the NF-κB pathway
por: Qiu, Jiangdong, et al.
Publicado: (2023)

Is neoadjuvant chemoradiotherapy for pancreatic cancer beneficial: A systematic review and meta-analysis
por: Luo, Wenhao, et al.
Publicado: (2022)

Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities
por: Jain, Aditi, et al.
Publicado: (2021)

Systemic Therapy of Metastatic Pancreatic Adenocarcinoma: Current Status, Challenges, and Opportunities
por: Chakrabarti, Sakti, et al.
Publicado: (2022)

Regulatory role of RNA modifications in the treatment of pancreatic ductal adenocarcinoma (PDAC)
por: Chen, Hao, et al.
Publicado: (2023)

Role of the microbiome in occurrence, development and treatment of pancreatic cancer
por: Wang, Yicheng, et al.
Publicado: (2019)

Current and emerging therapeutic strategies in pancreatic cancer: Challenges and opportunities
por: Manrai, Manish, et al.
Publicado: (2021)

Pancreatic Cancer: Challenges and Opportunities in Locoregional Therapies
por: Bazeed, Alaa Y., et al.
Publicado: (2022)

Novel discoveries targeting gemcitabine‐based chemoresistance and new therapies in pancreatic cancer: How far are we from the destination?
por: Luo, Wenhao, et al.
Publicado: (2019)

Pancreatic cancer: challenges and opportunities
por: Zhu, Huiyun, et al.
Publicado: (2018)

Immunotherapy and pancreatic cancer: unique challenges and potential opportunities
por: Young, Kate, et al.
Publicado: (2018)

Current Challenges and Opportunities of Photodynamic Therapy against Cancer
por: Huis in ‘t Veld, Ruben V., et al.
Publicado: (2023)

Metallic Biomaterials: Current Challenges and Opportunities
por: Prasad, Karthika, et al.
Publicado: (2017)

Current Challenges and Opportunities in Treating Glioblastoma
por: Shergalis, Andrea, et al.
Publicado: (2018)

Challenges, Opportunities and Theoretical Epidemiology
por: Brauer, Fred, et al.
Publicado: (2019)

MiR-1178 Promotes the Proliferation, G1/S Transition, Migration and Invasion of Pancreatic Cancer Cells by Targeting CHIP
por: Cao, Zhe, et al.
Publicado: (2015)

Environmental epidemiology: challenges and opportunities.
por: Pekkanen, J, et al.
Publicado: (2001)

The application of epidemiology in aquatic animal health -opportunities and challenges
por: Peeler, Edmund J, et al.
Publicado: (2011)

LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer
por: Feng, Mengyu, et al.
Publicado: (2018)

Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities
por: Lu, Chen, et al.
Publicado: (2019)

PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value
por: Xu, Jianwei, et al.
Publicado: (2016)

Challenges and Opportunities Associated With Platelets in Pancreatic Cancer
por: Chen, Zhou, et al.
Publicado: (2022)

The prospect of serum and glucocorticoid-inducible kinase 1 (SGK1) in cancer therapy: a rising star
por: Zhu, Ruizhe, et al.
Publicado: (2020)

Current Status, Opportunities, and Challenges of Exosomes in Oral Cancer Diagnosis and Treatment
por: Liu, Hongyu, et al.
Publicado: (2022)

Tumor Mutational Burden in Breast Cancer: Current Evidence, Challenges, and Opportunities
por: Barroso-Sousa, Romualdo, et al.
Publicado: (2023)

Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance
por: Greene, Michelle K., et al.
Publicado: (2021)

Building towards Precision Oncology for Pancreatic Cancer: Real-World Challenges and Opportunities
por: Wang, Yifan, et al.
Publicado: (2020)

Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities
por: Arias-Pinilla, Gustavo A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u015bqqg297gsh3ij2ojfsk7lo